This article is more than 5 years old. Information may no longer be current.
AACR names 11 academy fellows
Click Here to Manage Email Alerts
The American Association for Cancer Research announced 11 new fellows of the AACR Academy.
The academy recognizes distinguished scientists whose research has led to significant innovation and progress against cancer.
“Our 2015 class of fellows includes 11 luminaries in the field of cancer research, in honor of the 11 founders of the AACR in 1907,” Margaret Foti, PhD, MD (hc), chief executive officer of the AACR, said in a press release. “We are delighted to recognize the incredible scientific accomplishments of these illustrious researchers and celebrate how their dedicated efforts have helped accelerate the pace of progress against many of the hundreds of diseases we collectively call cancer.”
Members of the 2015 class of fellows of the AACR Academy are:
- Kenneth C. Anderson, MD, director of the Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at Dana-Farber Cancer Institute;
- Carlos L. Arteaga, MD, director of the Center for Cancer Targeted Therapies; director of the Breast Cancer Program; and associate director for clinical research at Vanderbilt-Ingram Cancer Center at Vanderbilt University;
- Anton J.M. Berns, PhD, senior group leader in the division of molecular genetics at Netherlands Cancer Institute in Amsterdam, and director of the Skoltech Center for Stem Cell Research in Moscow;
- Bruce A. Chabner, MD, director of clinical research at Massachusetts General Hospital;
- Ronald A. DePinho, MD, president of The University of Texas MD Anderson Cancer Center;
- Susan D. Desmond-Hellmann, MD, MPH, chief executive officer of the Bill & Melinda Gates Foundation;
- Robert N. Eisenman, PhD, member of the division of basic sciences at Fred Hutchinson Cancer Research Center;
- Douglas R. Lowy, MD, deputy director of the Center for Cancer Research; chief of the Laboratory of Cellular Oncology; and head of the Signaling and Oncogenesis Section at the NCI;
- Carol L. Prives, PhD, Da Costa professor at Columbia University;
- Steven A. Rosenberg, MD, PhD, chief of surgery at the NCI; and
- Craig B. Thompson, MD, president and CEO of Memorial Sloan Kettering Cancer Center.